Japan· JP-1124026C1115
トフィソパム
A tofisopam product containing トフィソパム, registered in Japan by 鶴原製薬, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Tofisopam is registered in 2 of 19 countries.
Countries holding a registration under ATC N05BA23 (tofisopam), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 1 of them publish a price we can compare per daily dose
Tofisopam · ATC N05BA23
2 / 19 countries
- Czechiaprice
- Japan
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- トフィソパム
- Manufacturer
- 鶴原製薬
- Country
- Japan (JP)
- ATC code
- N05BA23
- ATC class
- Tofisopam
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N05BA23
Tofisopam, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac408389-c0b9-4b1e-9c1c-aef497c8544b GET /v1/drugs/ac408389-c0b9-4b1e-9c1c-aef497c8544b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０％１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1124026C1115",
"category": "内用薬",
"price_yen": 10.4,
"generic_name": "トフィソパム",
"product_name_jp": null,
"therapeutic_class": "1124",
"transitional_expiry": null
}See everything about tofisopam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.